Active Ingredient(s):Ertapenem FDA Approved: * November 21, 2001 Pharm Company: *MERCK Category:Antibiotics
Ertapenem (trade name Invanz) is a carbapenem antibiotic medication for the treatment of infections of the abdomen, the lungs, the upper part of the female reproductive system, and diabetic foot, used in the form of infusions or injections.
The most common side effects include diarrhoea, nausea (feeling sick), headache, and problems around the area where the medicine is infused. It can significantly reduce the concentrations of valproic acid, an anti-seiz...
* May have multiple approval dates, manufacturers, or labelers. 5 Discussions
Invanz 1 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution